Actionable news
All posts from Actionable news
Actionable news in SUPN: Supernus Pharmaceuticals, Inc.,

Perilous Reversal Stock: Supernus Pharmaceuticals (SUPN)

Trade-Ideas LLC identified Supernus Pharmaceuticals ( SUPN) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Supernus Pharmaceuticals as such a stock due to the following factors:

  • SUPN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.1 million.
  • SUPN has traded 168,024 shares today.
  • SUPN is down 3.2% today.
  • SUPN was up 6.6% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in SUPN with the Ticky from Trade-Ideas. See the FREE profile for SUPN NOW at Trade-Ideas More details on SUPN: Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. SUPN has a PE ratio of 2. Currently there are 5 analysts that rate Supernus Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Supernus Pharmaceuticals has been 882,900 shares per day over the past 30 days. Supernus has a market cap of $790.2 million and is part of the health care...